EXICURE INC

Exicure HiTron Buys 1.2 M Shares at $4.50, Boosting Investor Confidence and Signaling Long‑Term Value

Insiders buy Exicure shares at $4.50, signaling confidence in its CAR‑T pipeline and hinting at a strategic shift that could lift stock value.

EXICURE INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

17/07/2026, 22:55

3 minutes to read

Exicure Insider Sales: Routine Portfolio Moves Amid Market Challenges

Exicure insider sales reveal routine portfolio moves amid a steep stock decline – watch future trades and clinical milestones for clues to its biotech strategy.

EXICURE INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

19/02/2026, 20:42

6 minutes to read

EXICURE INC

Exicure HiTron Buys 1.2 M Shares at $4.50, Boosting Investor Confidence and Signaling Long‑Term Value

Exicure Insider Sales: Routine Portfolio Moves Amid Market Challenges

Exicure HiTron Buys 1.2 M Shares at $4.50, Boosting Investor Confidence and Signaling Long‑Term Value